BelaxOmics - About Us

Pioneering the Future of Biological Insight

"Belax" is an abstract fusion representing balance (Be), legacy (La), and exploration (X) paired with Omics. Belaxomics focus on decoding the molecular mechanisms driving world’s deadliest diseases, responsible for millions of preventable deaths each year. Our expertise lies in advanced proteomics and integrated multi-omics solutions, enabling unprecedented insights at the molecular level. By combining state-of-the-art technologies with evidence-based research, we aim to transform disease diagnosis, prevention, and treatment. Our approach empowers personalized health strategies, precision therapies, and early detection tools tailored to individual needs. Belaxomics serves researchers and pharmaceutical innovators seeking to push the boundaries of biomedical science.

Together, we strive to create a future where complex diseases can be understood, targeted, and defeated.

Ram Prasad, Ph.D.

Founder and CEO

Dr. Prasad, Founder and CEO of Belaxomics, brings over 23 years of multidisciplinary expertise to deliver precision-driven, on-time research solutions. With a proven track record of his scientific journey (over 60 publications and 100 invited talks), he understands the needs of researchers and ensures Belaxomics is a trusted partner in transforming complex biology into meaningful discoveries. Belaxomics is committed to being a trusted partner, turning biological complexity into actionable insights that accelerate innovation and inspire confidence in every collaboration.

Jyoti Agarwal, MS, MB (ASCP), CGMBS

Co-Founder and Managing Director

Ms. Agarwal, Co-Founder and Managing Director of Belaxomics, holds an M.S. in Toxicology with a gold medal and prestigious certifications in MB (ASCP) and CGMBS. With over 15 years of management experience in clinical workflows, she drives seamless operations and ensures the on-time delivery of high-quality results, strengthening Belaxomics’ commitment to being a trusted partner for researchers worldwide.

Prof. Maria B. Grant, MD, FARVO

Scientific Advisor

Prof. Maria Grant is a globally acclaimed leader in retinal and stem cell biology, with over 300 publications and pioneering discoveries in organ crosstalk, including the gut-eye axis. Her work bridges fundamental research and translational medicine, advancing biomarkers, regenerative therapies, and disease prevention. At BelaxOmics, she guides cutting-edge proteomics and multi-omics research, translating complex biological insights into innovative therapeutic solutions.

Prof. Sanjeeva Srivastava, Ph.D.

Scientific Advisor

Prof. Srivastava, Scientific Advisor at Belaxomics, is a world-renowned proteomics expert with a Ph.D. from the University of Alberta and postdoctoral training at Harvard Medical School. A Professor at IIT Mumbai and visiting faculty at UCSF, he brings extensive expertise in proteomics, biotechnology, cancer, and infectious diseases. With a strong track record in research, patents, and global collaborations, he guides Belaxomics in delivering cutting-edge, precision-driven multi-omics solutions to the scientific community.

Prof. Marina Gorbatyuk, Ph.D.

Advisor, Translational Multi-Omics

Marina Gorbatyuk, Ph.D., is a professor at Wake Forest University School of Medicine and an internationally recognized scientist studying molecular mechanisms driving retinal degenerative and neurological disorders. Her research focuses on preserving neuronal health through advanced multi-omics strategies, seamlessly integrating fundamental biology with translational applications. Dr. Gorbatyuk’s work accelerates progress in biomarker discovery, regenerative medicine, and disease prevention. At BelaxOmics, she will advise on multi-omics initiatives, transforming complex biological data into actionable insights and innovative therapeutic solutions.

Page updated

Google Sites

Report abuse